— Know what they know.
Not Investment Advice

QLGN NASDAQ

Qualigen Therapeutics, Inc.
1W: +4.4% 1M: -6.3% 3M: +18.5% 1Y: -39.2% 3Y: -96.8% 5Y: -99.9%
$3.21
Last traded 2025-12-15 — delisted
NASDAQ · Healthcare · Biotechnology · $5.4M mcap · 2M float · 156.06% daily turnover · Short 48% of daily vol

Supply Chain Overview

3 relationships
0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2024-02-22
Earliest Filing
2025-09-25
Latest Filing

Mentioned As Counterparty

3 mentions

Other companies that named QLGN in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
FFAIW FARADAY FUTURE INTELLIGENT ELECTRIC INC. investor Faraday Future Intelligent Electric Inc. agreed to invest approximately $40.7 million in Qualigen Therapeutics, Inc. for 2025-09-25 View
AIXC Qualigen Therapeutics, Inc. partner Company entering into the placement agency agreement 2024-09-09 View
AIXC Qualigen Therapeutics, Inc. partner Licensor granting exclusive and non-exclusive sublicenses of RAS technology 2024-02-22 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms